GlobeNewswire - Industry News on Medical Equipment

Neovasc Comments on Journal of the American Heart Association Publication

Fri, 05 Feb 2021 14:00 GMT

VANCOUVER and MINNEAPOLIS, Feb. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ,?TSX: NVCN) today announced that the Journal of the American Heart Association has published an article entitled,?“Angina Severity, Mortality, and Healthcare Utilization Among Veterans with Stable Angina”. The prestigious journal is the official publication of the American Heart Association, and the article offers important insights into the burden of angina on both patients and healthcare systems.

Australia, a world-renowned surgical robotics market, introduces first Versius system

Fri, 05 Feb 2021 12:00 GMT

Australia, a world-renowned surgical robotics

CareDx Showcases Cellular Transplantation and Therapy Portfolio at TCT

Fri, 05 Feb 2021 12:00 GMT

CareDx and Atara Biotherapeutics’ AlloCell Partnership Highlighted in Poster Presentation at Upcoming TCT Meeting

CareDx and Atara Biotherapeutics’ AlloCell Partnership Highlighted in Poster Presentation at Upcoming TCT Meeting

Ambu A/S: Capital increase in connection with exercise of warrants issued

Fri, 05 Feb 2021 10:42 GMT

Capital increase in connection with exercise of warrants

Godt 1. halv?r med h?j oms?tningsv?kst og en forbedret EBITDA-margin

Fri, 05 Feb 2021 07:45 GMT

ChemoMetec opn?ede i 1. halv?r 2020/21 en oms?tning p? DKK 133,0 mio. svarende til en v?kst p? 28% i forhold til ?ret f?r. EBITDA steg med 53% til DKK 67,1 mio., og EBITDA-marginen blev forbedret til nu 51%.

Australia, a world-renowned surgical robotics market, introduces first Versius system

Fri, 05 Feb 2021 07:00 GMT

Australia, a world-renowned surgical robotics

Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning Competition

Thu, 04 Feb 2021 21:30 GMT

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc.?(NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the four winners of the Rare Lessons lesson planning competition. Sarepta has granted the winning authors $2,500 each and $2,500 to the educational institution with which each is affiliated. The winning submissions are now available on sharemylesson.com, and more information about the authors can be found at Sarepta.com/rarelessons.

Acutus Medical to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Thu, 04 Feb 2021 21:01 GMT

CARLSBAD, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021 at 2:00 p.m. Eastern Time.

IBA – ACQUISITION D’ACTIONS PROPRES

Thu, 04 Feb 2021 19:45 GMT

Publication immédiate – 4 février 2021

Iba – Acquisition of Own Shares

Thu, 04 Feb 2021 19:45 GMT

Stereotaxis to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

Thu, 04 Feb 2021 14:00 GMT

ST. LOUIS, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2020 fourth quarter and full year ended December 31, 2020 on Thursday, February 25, 2021 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments.

InspireMD Announces Pricing of Upsized $18 Million Underwritten Public Offering

Thu, 04 Feb 2021 13:30 GMT

TEL AVIV, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. ("InspireMD") (NYSE:NSPR), a medical device company focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East and Asia, today announced the pricing of an upsized underwritten public offering of securities for gross proceeds of $18 million (or $20.7 million if the underwriters exercise their option to purchase additional securities) prior to deducting underwriting discounts and estimated offering expenses payable by InspireMD.

Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing

Thu, 04 Feb 2021 13:30 GMT

Loughborough, England, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces the appointment of Thomas Mortensen as head of E.U. commercial operations and marketing.

Microbot Medical Granted Patent Allowance in Japan; Global Jurisdictions Recognizing Novel ‘One & Done’ Technology

Thu, 04 Feb 2021 12:00 GMT

HINGHAM, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has received official notification from the Japan Patent Office (JPO) that it intends to grant the Company a patent for its ‘One & Done’ guidewire technology for use with endoluminal interventions. Japan is the second jurisdiction to grant a patent for the ‘One & Done’ guidewire technology and further protects the novel technology the Company is currently developing.

IRADIMED CORPORATION Announces Fourth Quarter 2020 Financial Results

Thu, 04 Feb 2021 12:00 GMT

WINTER SPRINGS, Fla., Feb. 04, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures, today announced financial results for the three months and year ended December 31, 2020.

Philips signs multiyear strategic partnership agreement for connected care solutions with 28-hospital Dutch SAZ group

Thu, 04 Feb 2021 10:00 GMT

February 4, 2021

Inovalon Reports Fourth Quarter and Full Year 2020 Results

Wed, 03 Feb 2021 21:10 GMT

Fourth Quarter 2020 Highlights

Inari Medical to Present in Upcoming Investor Conferences

Wed, 03 Feb 2021 21:01 GMT

IRVINE, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its management team will present at the following upcoming investor conferences:

IBA – Transparency Notification

Wed, 03 Feb 2021 19:10 GMT

?Tab A Tab A Tab B Tab B

IBA - NOTIFICATION DE TRANSPARENCE

Wed, 03 Feb 2021 19:10 GMT